Gilead DRN (GILD34)
BOV
The current GILD34 market cap is 324.87B. The company's latest EPS is USD 4.5464 and P/E is 19.75.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 6.6B | 7.05B | 7.11B | 6.69B | 6.95B |
Operating Income | 1.67B | 2.63B | 1.61B | -4.32B | 2.64B |
Net Income | 1.05B | 2.18B | 1.43B | -4.17B | 1.61B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 22.45B | 24.69B | 27.31B | 27.28B | 27.12B |
Operating Income | 4.29B | 4.07B | 9.92B | 7.33B | 7.61B |
Net Income | 5.39B | 123M | 6.23B | 4.59B | 5.67B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 62.34B | 62.37B | 62.13B | 56.29B | 53.58B |
Total Liabilities | 41.24B | 40.13B | 39.38B | 38.84B | 35.38B |
Total Equity | 21.09B | 22.24B | 22.75B | 17.46B | 18.2B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 61.63B | 68.41B | 67.95B | 63.17B | 62.13B |
Total Liabilities | 38.98B | 50.19B | 46.89B | 41.96B | 39.38B |
Total Equity | 22.65B | 18.22B | 21.06B | 21.21B | 22.75B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 4.08B | 5.84B | 8.01B | 2.22B | 3.54B |
Investing | -1.31B | -1.54B | -2.27B | -2.21B | -2.51B |
Financing | -2.51B | -4.03B | -5.13B | -1.36B | -4.31B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 9.14B | 8.17B | 11.38B | 9.07B | 8.01B |
Investing | -7.82B | -14.62B | -3.13B | -2.47B | -2.27B |
Financing | -7.63B | 770M | -8.88B | -6.47B | -5.13B |
Market Cap | 324.87B |
Price to Earnings Ratio | 19.75 |
Price to Sales Ratio | 4.13 |
Price to Cash Ratio | 18.39 |
Price to Book Ratio | 4.92 |
Dividend Yield | 2.32% |
Shares Outstanding | 1.25B |
Average Volume (1 week) | 72 |
Average Volume (1 Month) | 60 |
52 Week Change | 41.24% |
52 Week High | 261.04 |
52 Week Low | 163.57 |
Spread (Intraday) | 0.97 (0.37%) |
Company Name | Gilead DRN |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.gilead.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.